Epicutaneous Immunotherapy with CBir1 Alleviates Intestinal Inflammation.

Inflammatory bowel diseases（2023）

引用 1|浏览9

暂无评分

摘要

Epicutaneous immunotherapy with MEP1 induced Tregs that migrate to intestines and suppress inflammation in mice with CBir1 or A4Fla2-positive bacterial colonization. This could be a potential strategy to treat CD and warrants further study.

查看译文

关键词

CBir1,colitis,epicutaneous immunotherapy,flagellin,tolerance

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要